+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2023-2030- Product Image
Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2023-2030- Product Image
Sale

Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896809
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transdermal Drug Delivery System Market size was estimated at USD 6.66 billion in 2022, USD 6.98 billion in 2023, and is expected to grow at a CAGR of 5.03% to reach USD 9.87 billion by 2030.

Transdermal drug delivery comprises the production, distribution, and application of therapeutic methods that facilitate the controlled release of medications through the skin. This innovative approach offers numerous advantages over conventional oral or intravenous drug administration, such as increased patient compliance, reduced side effects, and improved pharmacokinetic profiles. The TDDS encompasses various technologies, including passive diffusion systems, iontophoresis, microneedles, and ultrasound-mediated techniques. The increase in the aging population and the growing prevalence of chronic diseases necessitate more practical and convenient drug delivery methods. Furthermore, advancements in nanotechnology and materials science have enabled the development of sophisticated transdermal patches that offer superior drug permeation across biological membranes without causing irritation or discomfort to patients. However, high development costs associated with producing complex transdermal systems and incidences of product recalls may adversely impact their use in the healthcare sector. Besides, advanced drug delivery vehicles demonstrate promising potential to improve the bioavailability and solubility of water-soluble drugs, enabling more effective transdermal drug delivery strategies.

Regional Insights

The transdermal drug delivery market is evolving in the Americas due to its well-established healthcare infrastructure and research & development activities. Regulatory bodies in the Americas ensure adherence to standard guidelines while approving new products, resulting in the development of innovative transdermal technologies. The APAC region has a growing demand for advanced healthcare technologies due to increasing disposable incomes, population aging, and the need for efficient treatments. The transdermal drug delivery system market is growing in the EMEA region due to the presence of pharmaceutical industries, increased healthcare spending, and the rapid expansion of its manufacturing capabilities for transdermal systems. Moreover, the increasing adoption of personalized medicine and targeted therapies presents further prospects for TDDS systems tailored to specific patient populations or disease conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transdermal Drug Delivery System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transdermal Drug Delivery System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AdhexPharma, SAS, Bayer AG, Biotts Inc., Boehringer Ingelheim International GmbH, DuPont de Nemours, Inc., Gensco Pharma, Hisamitsu Pharmaceutical Co., Inc., IBSA Farmaceutici Italia Srl, IntelGenx Corp., Johnson & Johnson Services, Inc., Kindeva Drug Delivery L.P., Lavipharm S.A., Lead Chemical Co., Ltd., Luye Life Sciences Group, Medherant Limited, Nitto Denko Corporation, Novartis International AG, Nutriband Inc., Purdue Pharma L.P., Sorrento Therapeutics, Inc., Sparsha Pharma International Pvt. Ltd., Starton Therapeutics, Toa Eiyo Ltd., Toyo Ink SC Holdings Co., Ltd., Transdermal Therapeutics, Inc., UCB S.A., Viatris Inc., Zhongshan Senwell Bio Technology Co., Ltd., and Zynerba Pharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Transdermal Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Transdermal Patches
      • Drug-In-Adhesive Patches
      • Matrix Patches
      • Microneedle Patches
      • Reservoir Membrane Patches
    • Transdermal Semisolids
      • Gels
      • Ointments
      • Sprays
  • Application
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Hormonal Applications
    • Pain Management
    • Transdermal Estrogen Therapy
  • End User
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Transdermal Drug Delivery System Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transdermal Drug Delivery System Market?
  3. What are the technology trends and regulatory frameworks in the Transdermal Drug Delivery System Market?
  4. What is the market share of the leading vendors in the Transdermal Drug Delivery System Market?
  5. Which modes and strategic moves are suitable for entering the Transdermal Drug Delivery System Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transdermal Drug Delivery System Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases and the need for effective drug delivery
5.1.1.2. Surging adoption of third-generation transdermal drug delivery system
5.1.2. Restraints
5.1.2.1. Concerns associated with irritation or skin sensitivity over patch usage
5.1.3. Opportunities
5.1.3.1. Ongoing research & development in transdermal drug delivery system
5.1.3.2. Inorganic growth strategies between pharmaceutical companies and TDDS vendors
5.1.4. Challenges
5.1.4.1. Probable risk of drug failure through transdermal systems and product recalls
5.2. Market Segmentation Analysis
5.2.1. Type: Ongoing regulatory and government approvals for transdermal patches
5.2.2. Application: Need for minimally invasive drug delivery systems for management of cardiovascular diseases
5.2.3. End-User: Preference for self-administration of drugs leading to demand for drug delivery systems that can be implemented in home care settings
5.3. Market Trend Analysis
5.3.1. Potential power of market players and surge in regulatory approvals in the American region
5.3.2. Surging healthcare spendings and inclusion of overseas players in the APAC region
5.3.3. Persistent research activities and the growing burden of chronic disease in the EMEA region.
5.3.4. Revolutionizing transdermal drug delivery with electronic skin
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Transdermal Drug Delivery System Market, by Type
6.1. Introduction
6.2. Transdermal Patches
6.3.1. Drug-In-Adhesive Patches
6.3.2. Matrix Patches
6.3.3. Microneedle Patches
6.3.4. Reservoir Membrane Patches
6.3. Transdermal Semisolids
6.4.1. Gels
6.4.2. Ointments
6.4.3. Sprays
7. Transdermal Drug Delivery System Market, by Application
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Central Nervous System Disorders
7.4. Hormonal Applications
7.5. Pain Management
7.6. Transdermal Estrogen Therapy
8. Transdermal Drug Delivery System Market, by End User
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Clinics
9. Americas Transdermal Drug Delivery System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transdermal Drug Delivery System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transdermal Drug Delivery System Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. LTS Completes Its Entry Into Large Molecule Drug Delivery With The Acquisition Of The Sorrel Wearable Injection Device Business
12.3.1.2. DifGen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc.
12.3.1.3. Kindeva Merges with Meridian to Create Global CDMO Specializing in Drug-Device Combinations
12.3.1.4. Love Pharma Moves To Buy Transdermal Opioid-Use Disorder Player
12.3.1.5. Lowenstein Represents Pharma Tech LTS Lohmann Therapy Systems, Corp. in Acquisition of Tapemark Inc.
12.3.2. New Product Launch & Enhancement
12.3.2.1. Corium Launches ADLARITY (donepezil transdermal system) for Patients with Alzheimer's Dementia
12.3.3. Investment & Funding
12.3.3.1. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
12.3.4. Award, Recognition, & Expansion
12.3.4.1. Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved in China for the Treatment of Alzheimer's Disease
12.3.4.2. Satio Wins USD 3.5 Million Contract To Develop At-Home Transdermal Drug Delivery Device
12.3.4.3. Zydus Lifesciences gets Final Approval from the U.S. FDA to Market Estradiol Transdermal System
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. AdhexPharma, SAS
13.1.3. Bayer AG
13.1.4. Biotts Inc.
13.1.5. Boehringer Ingelheim International GmbH
13.1.6. DuPont de Nemours, Inc.
13.1.7. Gensco Pharma
13.1.8. Hisamitsu Pharmaceutical Co., Inc.
13.1.9. IBSA Farmaceutici Italia Srl
13.1.10. IntelGenx Corp.
13.1.11. Johnson & Johnson Services, Inc.
13.1.12. Kindeva Drug Delivery L.P.
13.1.13. Lavipharm S.A.
13.1.14. Lead Chemical Co., Ltd.
13.1.15. Luye Life Sciences Group
13.1.16. Medherant Limited
13.1.17. Nitto Denko Corporation
13.1.18. Novartis International AG
13.1.19. Nutriband Inc.
13.1.20. Purdue Pharma L.P.
13.1.21. Sorrento Therapeutics, Inc.
13.1.22. Sparsha Pharma International Pvt. Ltd.
13.1.23. Starton Therapeutics
13.1.24. Toa Eiyo Ltd.
13.1.25. Toyo Ink SC Holdings Co., Ltd.
13.1.26. Transdermal Therapeutics, Inc.
13.1.27. UCB S.A.
13.1.28. Viatris Inc.
13.1.29. Zhongshan Senwell Bio Technology Co., Ltd.
13.1.30. Zynerba Pharmaceuticals, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2022 VS 2030
FIGURE 3. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET DYNAMICS
FIGURE 7. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 12. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 8. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 14. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 44. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 45. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 49. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 71. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 72. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 76. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 77. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 86. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 116. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 132. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 137. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 142. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 147. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 152. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 162. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 163. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 177. NORWAY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 182. POLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 183. POLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 187. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 188. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 207. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 222. TURKEY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 236. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2022
TABLE 237. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • AdhexPharma, SAS
  • Bayer AG
  • Biotts Inc.
  • Boehringer Ingelheim International GmbH
  • DuPont de Nemours, Inc.
  • Gensco Pharma
  • Hisamitsu Pharmaceutical Co., Inc.
  • IBSA Farmaceutici Italia Srl
  • IntelGenx Corp.
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery L.P.
  • Lavipharm S.A.
  • Lead Chemical Co., Ltd.
  • Luye Life Sciences Group
  • Medherant Limited
  • Nitto Denko Corporation
  • Novartis International AG
  • Nutriband Inc.
  • Purdue Pharma L.P.
  • Sorrento Therapeutics, Inc.
  • Sparsha Pharma International Pvt. Ltd.
  • Starton Therapeutics
  • Toa Eiyo Ltd.
  • Toyo Ink SC Holdings Co., Ltd.
  • Transdermal Therapeutics, Inc.
  • UCB S.A.
  • Viatris Inc.
  • Zhongshan Senwell Bio Technology Co., Ltd.
  • Zynerba Pharmaceuticals, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 6.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.87 Billion
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Forecast 2023-2030 - Product Image

Global Transdermal Patches Market by Product (Matrix, Multi-layer Drug-in-Adhesive, Reservoir), Type (Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Fentanyl Transdermal Patch), Technology, Application, Distribution Channel, End Users - Forecast 2023-2030

  • Report
  • 188 Pages
  • Global
From
Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Iontophoresis, Mechanical Arrays), By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Iontophoresis, Mechanical Arrays), By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Transdermal Drug Delivery Market 2024-2028 - Product Image

Global Transdermal Drug Delivery Market 2024-2028

  • Report
  • 168 Pages
  • Global
From
Transdermal Drug Delivery System Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel - Product Image

Transdermal Drug Delivery System Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel

  • Report
  • 233 Pages
  • Global
From
Global Transdermal Drug Delivery System Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Transdermal Drug Delivery System Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 146 Pages
  • Global
From

About the Transdermal Drug Delivery Market

The Transdermal Drug Delivery market is a segment of the Medical Devices industry that focuses on the delivery of drugs through the skin. This method of drug delivery is advantageous as it can provide a steady, controlled release of medication over a period of time. Transdermal drug delivery systems are typically composed of a drug-containing patch, which is applied to the skin. The patch is designed to allow the drug to pass through the skin and into the bloodstream. Transdermal drug delivery systems are used to treat a variety of conditions, including pain, allergies, and hormone replacement therapy. They are also used to deliver drugs that are not easily absorbed through the digestive system. The Transdermal Drug Delivery market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include 3M, Johnson & Johnson, Novartis, and Mylan. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.